Results 111 to 120 of about 90,099 (199)

Amonafide Targeting NTSR1-PI3K/AKT/mTOR Signaling Attenuates Vascular Remodeling in Pulmonary Arterial Hypertension. [PDF]

J Am Heart Assoc
Zhu YJ, Kou JJ, Bo YC, Zhang MJ, Fan X, Zhao LL, Yan Y, Zhang HD, Wu WH, Yuan P, Liu Y, Shi JZ, Pang XB, He YY.   +13 more
europepmc   +1 more source

Identification of a <i>TOP3A</i> genetic variant as a novel biomarker for sensitivity to doxorubicin. [PDF]

Front Pharmacol
Takacova T, Schirmer MA.
europepmc   +1 more source

Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer: Current Evidence and Evolving Considerations: JACC: CardioOncology Primer. [PDF]

JACC CardioOncol
Moore H, Huppert LA, Moslehi JJ, Yang EH, Hatcher S, Thomas A.   +5 more
europepmc   +1 more source

Advances and Future Directions in Antibody-Drug Conjugates: From Paradigm Shifts to Data-Driven Design. [PDF]

Cancers (Basel)
Kumari S, Cool LM, Howard E, Pawar JS.
europepmc   +1 more source

Scleroderma-Specific Autoantibodies and Disease Trajectories in Early Systemic Sclerosis: Insights From a Single-Center Prospective Registry. [PDF]

ACR Open Rheumatol
Jamali M, Kaur A, Huang S, Zahn C, Mulcaire-Jones E, Varga J, Khanna D.   +6 more
europepmc   +1 more source

Flavonoids as Dual Topoisomerase I and II Inhibitors: Mechanistic Insights and Emerging Anticancer Strategies. [PDF]

Chem Biodivers
Parua P, Bag S, Sisodiya D, Jana K, Ghosh A, Debnath B, Ghosh G, Rath G.   +7 more
europepmc   +1 more source

Gastrointestinal Symptoms in Systemic Sclerosis: Prevalence and Severity across Disease Subtypes and Autoantibody Profiles. [PDF]

Acta Med Litu
Šestakov MV, Lukovic S, Pavlovic I, Zlatanovic M, Ostojic P.   +4 more
europepmc   +1 more source

HIF inhibition: Current strategies and clinical challenges. [PDF]

Redox Biol
Więch-Walów A, Bartoszewska S, Barton A, Czechowicz P, Dudzik J, Wielockx B, Collawn JF, Bartoszewski R.   +7 more
europepmc   +1 more source

Correction: Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activity. [PDF]

Front Pharmacol
Eldehna WM, Tawfik HO, Veselá D, Peřina M, Negmeldin AT, Elsayed ZM, Majrashi TA, Vojáčková V, Elbadawi MM, Shaldam MA, Kryštof V, Abdel-Aziz HA.   +11 more
europepmc   +1 more source

From Solid Tumor to Hematologic Malignancy: A Case Report of Acute Promyelocytic Leukemia Following Breast Cancer Treatment. [PDF]

Cureus
Tahir A, Ahmad N, Ahsan B, Asif H, Khan MH.   +4 more
europepmc   +1 more source